MedPath

Devert-50

Brand Name: Devert-50

Generic Name: Desvenlafaxine (as succinate monohydrate)

Active
Registration Number

DR-XY48757

Dosage Form

Controlled-Release Tablet

Issuance Date

June 1, 2023

Expiry Date

June 1, 2028

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength50 mg
PackagingAlu/Alu blister pack x 10's (Box of 30's)

Classification

C
Classification
Prescription Drug (RX)
A
Application
Monitored Release (MR)
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Desvenlafaxine (as succinate monohydrate)Active
Monograph: desvenlafaxine (as succinate monohydrate)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform